# 2019 Cannabinoid Function in the CNS GRC & GRS

> **NIH NIH R13** · GORDON RESEARCH CONFERENCES · 2020 · $1

## Abstract

PROJECT SUMMARY
Cannabinoid signaling in the CNS is composed of Cannabinoid receptors CB1 and CB2 and their cognate
exogenous and endogenous ligands. Cannabinoid signaling is widely distributed throughout the CNS and it
is implicated in a wide variety of important neurobiological processes including reward signaling and
addiction, regulation of energy homeostasis, learning and memory, motor function, anxiety, and social
function. Therefore, understanding the neurobiology of cannabinoid signaling could have broad implications
for physiological CNS function and the pathophysiology of neuropsychiatric disorders. The Gordon Research
Conference (GRC) on “Cannabinoid Functions in the CNS” and its associated Gordon Research Seminar
(GRS) represent the quintessential scientific forums in the field of cannabinoid function in the CNS. This
GRC meeting has a strong reputation for attracting the most active and renowned scientists in the field and
it is the “must attend” meeting for trainees aiming to become the next generation of cannabinoid
neuroscientists. In this renewal application, we request continued financial support to partially cover
expenses for predoctoral and postdoctoral trainees to attend the 2019 and 2021 “Cannabinoid
Functions in the CNS” GRS/GRC meetings. The primary aims of this conference are: 1) To provide
outstanding scientific programs in the traditions and spirit of the Gordon Research Conferences. These
include an emphasis on cutting-edge unpublished data by leaders in the field including a Nobel laureate,
who has already agreed to present new work; a community atmosphere that fosters informal discussion and
stimulates new collaborations, and on inclusion of plenary speakers outside of the field that could stimulate
new areas of cannabinoid research, and 2) To foster the development of young scientists and trainees in the
field. This will be executed primarily via organization of the GRS focused on increasing professional networks
of young scientists, providing a venue for oral scientific presentation for trainees, and organization of career
development seminars. A second and novel approach for this meeting will be the implementation of a
mentoring system during the GRC to increase 1:1 interactions between trainees and senior scientists in the
field. The “Cannabinoid Functions in the CNS” GRS/GRC is widely regarded as the pinnacle of meetings in
the cannabinoid field and has several unique qualities including a 1) focus on the CNS, which is not present
at any other Cannabinoid centered meeting, 2) strong emphasis on cutting-edge unpublished data, 3)
continuing commitment to trainees through organization of the GRS, trainee mentoring program, and career
development panels including “Women in Science” and “Publishing 101 Q&A,” for example.
Discussions/debates focused on controversial topics will be new additions to this funding cycle.

## Key facts

- **NIH application ID:** 9891042
- **Project number:** 5R13DA047696-02
- **Recipient organization:** GORDON RESEARCH CONFERENCES
- **Principal Investigator:** Sachin Patel
- **Activity code:** R13 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $1
- **Award type:** 5
- **Project period:** 2019-04-01 → 2022-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9891042

## Citation

> US National Institutes of Health, RePORTER application 9891042, 2019 Cannabinoid Function in the CNS GRC & GRS (5R13DA047696-02). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/9891042. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*